Breaking News Instant updates and real-time market news.

PRQR

ProQR Therapeutics

$5.81

-0.37 (-5.99%)

14:55
10/10/19
10/10
14:55
10/10/19
14:55

ProQR Therapeutics price target raised to $40 from $34 at Citi

Citi analyst Yigal Nochomovitz raised his price target on ProQR Therapeutics to $40 from $34, stating that he disagree's with the market's initial take on the company's updated data on sepofarsen. Given his view that the 12-month data validate the treatment benefits observed at 3 months, Nochomovitz increased his odds on the success for sepofarsen in patients with Leber's congenital amaurosis 10 to 70% from 50% and keeps his Buy rating on the stock. In afternoon trading, ProQR shares are down 26c, or 4%, to $5.95.

  • 10

    Oct

  • 11

    Oct

PRQR ProQR Therapeutics
$5.81

-0.37 (-5.99%)

01/14/19
CANT
01/14/19
NO CHANGE
CANT
Cantor highlights BioMarin, ProQR after JPMorgan Healthcare Conference
Cantor Fitzgerald analyst Eliana Merle found BioMarin's (BMRN) gene therapy platform advances and "improved risk-reward" for ProQR Therapeutics' (PRQR) USH2A program ahead of key data mid-2019 as most notable from the JPMorgan Healthcare Conference. The analyst left feeling more confident about BioMarin's gene therapy platform, which she thinks could positively surprise over the next 12-24 months as new programs enter the clinic. Further, she thinks the safety events in question at this point are likely overdone in ProQR shares following the 15% selloff since the conference. Merle now sees an "even more" favorable risk/reward into the company's mid-2019 proof-of-concept readout from a separate program.
02/20/19
SBSH
02/20/19
NO CHANGE
SBSH
Buy
Citi opens 90-day catalyst watch on ProQR Therapeutics
Citi analyst Yigal Nochomovitz opened a 90-day catalyst watch on ProQR Therapeutics in anticipation of the interim Phase 1/2 Wings data for QR-313 in dystrophic epidermolysis bullosa. On positive data, or evidence of exon skipping in biopsies and evidence of skin lesion/blister resolution, the analyst sees the stock up 15%-25%. On negative data, he sees downside of 10%-15%. Nochomovitz has a Buy rating on ProQR Therapeutics.
03/27/19
CANT
03/27/19
NO CHANGE
Target $40
CANT
Overweight
ProQR Therapeutics spin-out 'smart, but not surprising,' says Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle thinks ProQR Therapeutics' spin-out of its dystrophic epidermolysis bullosa program is a "smart, but not surprising," strategic move. Given that the company has communicated it wants to focus on its ophthalmology programs, investors are unlikely to find this announcement about the skin program spin-out surprising, Merle tells investors in a research note. The analyst keeps an Overweight rating on ProQR Therapeutics with a $40 price target.
10/09/19
CANT
10/09/19
NO CHANGE
Target $40
CANT
Overweight
ProQR shares could more than double on tomorrow's data, says Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle reiterates an Overweight rating on ProQR Therapeutics with a $40 price target ahead of tomorrow's data update on lead program QR-110, which is in development for LCA10, a rare genetic form of blindness. Investors view ProQR and QR-110 as a "show-me story," but these data could lift a "significant overhang" around platform safety and serve as a "key piece of clinical de-risking" for QR-110's Phase 2/3 trial under way, Merle tells investors in a research note partially titled "A double by this time tomorrow?". The analyst thinks the stock could trade up 50%-150% tomorrow versus downside to its cash position of ~$2 per share, or ~65%.

TODAY'S FREE FLY STORIES

F

Ford

$8.78

0.145 (1.68%)

09:22
10/14/19
10/14
09:22
10/14/19
09:22
Hot Stocks
Ford reports Q3 Europe sales up 3.1% to 313,400 vehicles »

Ford sales grew more than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ACM

Aecom

$37.14

0.35 (0.95%)

, LPG

Dorian LPG

$11.48

0.22 (1.95%)

09:21
10/14/19
10/14
09:21
10/14/19
09:21
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Aecom (ACM), up…

ACM

Aecom

$37.14

0.35 (0.95%)

LPG

Dorian LPG

$11.48

0.22 (1.95%)

LYFT

Lyft

$39.49

1.8 (4.78%)

WDC

Western Digital

$58.36

1.09 (1.90%)

FLXN

Flexion

$13.37

0.125 (0.94%)

AMTD

TD Ameritrade

$35.27

0.78 (2.26%)

IPGP

IPG Photonics

$136.12

6.24 (4.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 30

    Oct

  • 07

    Nov

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

YNDX

Yandex

$29.95

-5.62 (-15.80%)

09:19
10/14/19
10/14
09:19
10/14/19
09:19
Recommendations
Yandex analyst commentary  »

Foreign ownership limit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

AMCX

AMC Networks

$48.42

0.89 (1.87%)

09:19
10/14/19
10/14
09:19
10/14/19
09:19
Downgrade
AMC Networks rating change  »

Evercore downgrades AMC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
10/14/19
10/14
09:18
10/14/19
09:18
Options
Overnight activity included 332 trades in SPX and 7 trades in VIX »

332 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$169.06

1.255 (0.75%)

, ABBV

AbbVie

$73.66

1.39 (1.92%)

09:17
10/14/19
10/14
09:17
10/14/19
09:17
Hot Stocks
Allergan shareholders approve AbbVie acquisition proposal »

Allergan (AGN) announced…

AGN

Allergan

$169.06

1.255 (0.75%)

ABBV

AbbVie

$73.66

1.39 (1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TOL

Toll Brothers

$39.49

0.2 (0.51%)

09:16
10/14/19
10/14
09:16
10/14/19
09:16
Downgrade
Toll Brothers rating change  »

Toll Brothers downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBT

Global Blood Therapeutics

$46.49

0.61 (1.33%)

09:16
10/14/19
10/14
09:16
10/14/19
09:16
Recommendations
Global Blood Therapeutics analyst commentary  »

Global Blood Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

AMGN

Amgen

$200.76

2.05 (1.03%)

09:15
10/14/19
10/14
09:15
10/14/19
09:15
Initiation
Amgen initiated  »

Amgen resumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

JAZZ

Jazz Pharmaceuticals

$118.61

0.62 (0.53%)

09:13
10/14/19
10/14
09:13
10/14/19
09:13
Initiation
Jazz Pharmaceuticals initiated  »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBI

Pitney Bowes

$4.40

0.04 (0.92%)

09:13
10/14/19
10/14
09:13
10/14/19
09:13
Hot Stocks
Pitney Bowes issues statement on malware attack »

Pitney Bowes issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

INFY

Infosys

$10.97

-0.22 (-1.97%)

09:13
10/14/19
10/14
09:13
10/14/19
09:13
Downgrade
Infosys rating change  »

Infosys downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

ARGO

Argo Group

$67.34

1.4 (2.12%)

09:12
10/14/19
10/14
09:12
10/14/19
09:12
Hot Stocks
Argo Group holder Voce comments on SEC probe »

Voce Capital, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARW

Arrow Electronics

$74.22

1.095 (1.50%)

, TXN

Texas Instruments

$130.08

2.52 (1.98%)

09:11
10/14/19
10/14
09:11
10/14/19
09:11
Recommendations
Arrow Electronics, Texas Instruments analyst commentary  »

Longbow says Arrow…

ARW

Arrow Electronics

$74.22

1.095 (1.50%)

TXN

Texas Instruments

$130.08

2.52 (1.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BKI

Black Knight

$61.68

0.39 (0.64%)

09:11
10/14/19
10/14
09:11
10/14/19
09:11
Hot Stocks
Black Knight receives to patents from USPTO »

Black Knight announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

UPS

UPS

$116.06

0.76 (0.66%)

09:10
10/14/19
10/14
09:10
10/14/19
09:10
Hot Stocks
UPS launches Storage on Demand service »

UPS announced the launch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

HON

Honeywell

$163.52

2.63 (1.63%)

09:09
10/14/19
10/14
09:09
10/14/19
09:09
Hot Stocks
Honeywell finalizing new T55 engine to power U.S. Army's Chinook helicopters »

Honeywell is finalizing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

OKTA

Okta

$116.19

1.65 (1.44%)

, PING

Ping Identity

$16.47

0.45 (2.81%)

09:09
10/14/19
10/14
09:09
10/14/19
09:09
Initiation
Okta, Ping Identity, Zscaler, Crowdstrike initiated  »

Citi expands Software…

OKTA

Okta

$116.19

1.65 (1.44%)

PING

Ping Identity

$16.47

0.45 (2.81%)

ZS

Zscaler

$48.16

0.81 (1.71%)

CRWD

Crowdstrike

$60.24

-1.08 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 19

    Nov

  • 12

    Dec

  • 16

    Dec

ERIC

Ericsson

$8.44

0.2 (2.43%)

09:09
10/14/19
10/14
09:09
10/14/19
09:09
Hot Stocks
Ericsson and Watch Communications enter into partnership »

Watch Communications has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

OSTK

Overstock.com

$10.67

-0.18 (-1.66%)

09:08
10/14/19
10/14
09:08
10/14/19
09:08
Hot Stocks
Medici Land Governance signs MOU with St. Kitts and Nevis government »

Overstock.com announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMTL

Comtech

$31.24

0.51 (1.66%)

09:08
10/14/19
10/14
09:08
10/14/19
09:08
Hot Stocks
Comtech awarded $4.4M contract renewal »

Comtech announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RETA

Reata Pharmaceuticals

$95.80

9.86 (11.47%)

09:08
10/14/19
10/14
09:08
10/14/19
09:08
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$20.76

0.76 (3.80%)

09:06
10/14/19
10/14
09:06
10/14/19
09:06
Recommendations
Wendy's analyst commentary  »

Wendy's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

  • 13

    Nov

LAND

Gladstone Land

$11.87

(0.00%)

09:06
10/14/19
10/14
09:06
10/14/19
09:06
Hot Stocks
Gladstone Land clarifies certain aspects of external fee structure »

Gladstone Land offered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LMAT

LeMaitre

$31.29

-0.03 (-0.10%)

09:06
10/14/19
10/14
09:06
10/14/19
09:06
Hot Stocks
Admedus sells CardioCel, VascuCel patch business to LeMaitre for $A36.2M »

Admedus announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.